7.19

0.69% -0.05

After Hours: 7.19

Day One Biopharmaceuticals Inc (DAWN)

Overview News Price History Option Chain Financials Discussions Forecast

Day One Biopharmaceuticals Inc stock is traded at $7.19, with a volume of 854.71K. It is down -0.69% in the last 24 hours and up +0.98% over the past month. Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Previous Close:

$7.24

Open:

$7.27

24h Volume:

854.71K

Relative Volume:

0.57

Market Cap:

$736.49M

Revenue:

$187.64M

Net Income/Loss:

$-95.00M

P/E Ratio:

-7.5684

EPS:

-0.95

Net Cash Flow:

$-69.02M

1W Performance:

-1.51%

1M Performance:

+0.98%

6M Performance:

+0.98%

1Y Performance:

-48.20%

1-Day Range:

$7.11

$7.32

1-Week Range:

$7.11

$7.73

52-Week Range:

$5.635

$16.76

Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile

Name

Day One Biopharmaceuticals Inc

Sector

Healthcare (1142)

Industry

Biotechnology (637)

Phone

650 484-0899

Address

2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE

Employee

181

Twitter

Next Earnings Date

Latest SEC Filings

DAWN's Discussions on Twitter

Compare DAWN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DAWN Day One Biopharmaceuticals Inc	7.19	741.61M	187.64M	-95.00M	-69.02M	-0.95
VRTX Vertex Pharmaceuticals Inc	407.37	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	464.95	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	557.73	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	799.56	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	327.03	35.16B	4.56B	-176.77M	225.30M	-1.7177

Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-19-25	Initiated	Piper Sandler	Overweight
Oct-09-24	Reiterated	Needham	Buy
Aug-01-24	Upgrade	BofA Securities	Underperform → Buy
Apr-24-24	Reiterated	Needham	Buy
Apr-25-23	Downgrade	BofA Securities	Buy → Underperform
Feb-08-23	Initiated	CapitalOne	Overweight
Feb-03-23	Initiated	Oppenheimer	Perform
Dec-15-22	Initiated	H.C. Wainwright	Buy
Dec-14-22	Initiated	Needham	Buy
Dec-05-22	Initiated	Goldman	Buy
Dec-01-22	Initiated	BofA Securities	Buy

View All

Day One Biopharmaceuticals Inc Stock (DAWN) Latest News

11:29 AM

Statistical indicators supporting Day One Biopharmaceuticals Inc.’s strength2025 Fundamental Recap & Precise Trade Entry Recommendations - newser.com

11:29 AM

10:08 AM

Top chart patterns to watch in Day One Biopharmaceuticals Inc.July 2025 Review & Weekly Stock Performance Updates - newser.com

10:08 AM

10:00 AM

Automated trading signals detected on Day One Biopharmaceuticals Inc. - newser.com

10:00 AM

08:43 AM

What does recent volatility data suggest for Day One Biopharmaceuticals Inc.Inflation Watch & Daily Oversold Bounce Ideas - newser.com

08:43 AM

08:26 AM

Applying Wyckoff theory to Day One Biopharmaceuticals Inc. stock2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com

08:26 AM

12:33 PM

Is Day One Biopharmaceuticals Inc. stock oversold or undervaluedJuly 2025 Setups & AI Forecast Swing Trade Picks - newser.com

12:33 PM

Oct 11, 2025